Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT.

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hepatoblastoma is a rare carcinoma mostly seen in children. Neoadjuvant chemotherapy followed by resection and adjuvant chemotherapy is the optimal treatment. We present the case of an 18-year-old woman who presented with abdominal pain, nausea, bloating, and fatigue. MRI showed 3 hepatic lesions with high signal intensity on arterial phase T1-weighted images and slight washout on the late phase, suggestive for hepatocellular carcinoma. Laboratory examinations revealed plasma α-feto-protein of 114,245 μg/L. Subsequent baseline and posttreatment F-fluoromethyl choline PET/CT were performed to possibly evaluate extent of the disease and assess disease response after neoadjuvant chemotherapy.

Cite

CITATION STYLE

APA

Bieze, M., van Gulik, T. M., & Bennink, R. J. (2013). Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT. Clinical Nuclear Medicine, 38(2). https://doi.org/10.1097/rlu.0b013e318252d7ea

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free